| Active substance |
Alfuzosin |
| Also known as |
Alfusozine, Xatral |
| Blood pressure |
May cause a decrease in blood pressure |
| Category |
Categories |
| Chemical name |
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]tetrahydro-2-furancarboxamide |
| Dosage |
10 Mg |
| Dosage (medical) |
Typically 10 mg once daily |
| Dosage (sports) |
Not applicable |
| Dosage Unit |
Tabs |
| ean13 |
1395574700708 |
| Effects |
Reduces symptoms of benign prostatic hyperplasia (BPH) |
| FORM |
Oral |
| Formula |
C19H27N5O4 |
| Half-life |
10 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Not specific |
| Main action |
Relaxation of smooth muscles in the prostate and bladder neck |
| Reference |
SPRM071 |
| Side effects |
Dizziness, headache, fatigue, orthostatic hypotension |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Alpha-1 blocker |
| Tab Piece |
30 Tabs |
| Trade name |
Uroxatral |
| Use in sports |
None |
| Water Retention |
Minimal |
| Packing |
Blister |
